The current study included several important parameters, including vitamin D level, parathyroid hormone, thyroid and thyroid stimulating hormones, and inflammatory markers, which might associate with development of osteoporosis in SSc patients and also excluded the comorbid conditions that might confound BMD measurement (i.e., cancer undergoing chemotherapy, chronic kidney disease, hypothyroidism). The gene discussed is PTH; the disease is systemic sclerosis.